Moderna Q2 Results Top Estimates

Biotechnology company Moderna reported a profit for the second quarter that increased from last year, reflecting improved revenues on commercial sales of the company's COVID-19 vaccine in the U.S. Both earnings per share and revenues for the quarter topped analysts' expectations. The company also sees product sales for the fourth quarter to be higher than the third quarter.